[1]
Maji, D. and Samanta, S. 2015. A REVIEW ON THE ROLE OF PPARγ AGONISTS AND HYBRIDS IN TYPE 2 DIABETES AND CARDIOMYOPATHY. Asian Journal of Pharmaceutical and Clinical Research. 8, 2 (Mar. 2015), 26–31.